title: [Treatment of anemia in Patient Blood Management from an economic perspective].
abstract: The liberal use of transfusions is not only a risk for patients but also represents a significant healthcare expenditure. The rational use of allogeneic blood transfusions and the use of transfusion alternatives, such as the optimization of preoperative hemoglobin levels, can offer substantial savings to health departments by reducing the cost of transfusions and the morbidity related to the transfusions.
authors: Servicio de Anestesiología y Reanimación, Hospital del Mar, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, España. Electronic address: ebisbe@parcdesalutmar.cat.
authors: E
authors: E
authors: Bisbe Vives
mesh_terms: D000740:Anemia / Q000191:economics* / Q000209:etiology / Q000628:therapy; D001771:Blood Banks / Q000191:economics; D016063:Blood Loss, Surgical; D001803:Blood Transfusion / Q000191:economics* / Q000706:statistics & numerical data; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D004921:Erythropoietin / Q000191:economics / Q000627:therapeutic use; D006397:Hematinics / Q000191:economics / Q000627:therapeutic use; D006403:Hematologic Tests / Q000191:economics; D017721:Hospital Costs; D006801:Humans; D007501:Iron / Q000191:economics / Q000627:therapeutic use; D019990:Perioperative Care / Q000191:economics*; D011183:Postoperative Complications / Q000191:economics / Q000209:etiology / Q000628:therapy; D011994:Recombinant Proteins / Q000191:economics / Q000627:therapeutic use; D012306:Risk; D065227:Transfusion Reaction
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D007501:Iron
keywords: Ahorro; Anemia; Savings; Transfusion; Transfusión